MedTrace Logo

Cognitive Assessments in Patients With Cancer Undergoing Chemotherapy

NCT01506440 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 29

Last updated 2018-07-03

No results posted yet for this study

Summary

This pilot clinical trial studies cognitive assessments in patients with cancer undergoing chemotherapy. Questionnaires that measure cognitive changes during chemotherapy may help identify the side effects of chemotherapy.

Conditions

  • Malignant Neoplasm
  • Unspecified Adult Solid Tumor, Protocol Specific

Interventions

PROCEDURE

cognitive assessment

Given cognitive assessments

PROCEDURE

quality-of-life assessment

Ancillary studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Heidi Klepin, MD · Wake Forest University Health Sciences

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2012-10-31
Completion
2012-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01506440 on ClinicalTrials.gov